Four telehealth bills could be signed into law over the next year by Congress; President Donald Trump mentioned "right-to-try" legislation in a favorable light in his State of the Union speech; the House Energy and Commerce Committee will hold legislation hearings on the opioid crisis February 26.
Four telehealth bills could be signed into law over the next year, which could resolve the issue of how to reimburse Medicare providers and save potentially billions in public funding. Reuters quoted one analyst who said roughly $135 billion of Medicare's annual $675 billion in spending could be done by telehealth. Two issues to be fixed: how to charge across state lines, and getting Medicare to recognize medical consultations that are not face-to-face as the equivalent of a personal visit to a healthcare provider.
President Donald Trump endorsed efforts by Congress to pass so-called “right-to-try” legislation, which would allow access to experimental treatments for patients with terminal conditions. STAT reported the president’s comments in the State of the Union speech were the first about the issue in nearly a year. The Senate passed legislation last fall but the effort has stalled in the House.
The House Energy and Commerce Committee will begin holding legislative hearings on measures to fight the opioid crisis the week of February 26, The Hill reported. The panel said that there will be multiple hearings to consider legislation aimed at fighting opioid use disorder. Earlier this month, the bipartisan National Governors Association called on Congress and the Trump administration to come up with more funding and coordinate on a response to the crisis, the Associated Press reported.
Shaping Dermatology's Future by Increasing Access, Data, and Advocacy
March 7th 2025Thy N. Huynh, MD, FAAD, Bruce A. Brod, MHCI, MD, FAAD, and Melissa Piliang, MD, FAAD, discussed expanding access to pediatric dermatology, dermatology data aggregation, and advocacy for Medicare physician payment reform, respectively.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Eliminating Enhanced PTCs Would Have Cascading Economic Impacts, Report Estimates
March 6th 2025Enhanced premium tax credits (PTCs) have made marketplace health insurance more affordable, and eliminating them could have sweeping impacts on consumers and the health care industry, according to a new report.
Read More
Addressing Health Care Disparities Using a Health Plan Quality Measures Index
February 26th 2025The Health Insurance Disparities Index allows stakeholders to assess progress in addressing health care disparities using publicly available, validated, reported health plan quality metrics results.
Read More